Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H34N2O7 |
Molecular Weight | 450.5253 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC1=CC=C(CC2=C(C)N(N=C2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C(C)C)C=C1
InChI
InChIKey=GSINGUMRKGRYJP-VZWAGXQNSA-N
InChI=1S/C23H34N2O7/c1-12(2)25-14(5)17(10-15-6-8-16(9-7-15)30-13(3)4)22(24-25)32-23-21(29)20(28)19(27)18(11-26)31-23/h6-9,12-13,18-21,23,26-29H,10-11H2,1-5H3/t18-,19-,20+,21-,23+/m1/s1
Molecular Formula | C23H34N2O7 |
Molecular Weight | 450.5253 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 21:31:55 UTC 2023
by
admin
on
Fri Dec 15 21:31:55 UTC 2023
|
Record UNII |
13ZPK7A4MJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
329045-45-6
Created by
admin on Fri Dec 15 21:31:55 UTC 2023 , Edited by admin on Fri Dec 15 21:31:55 UTC 2023
|
PRIMARY | |||
|
DTXSID30186563
Created by
admin on Fri Dec 15 21:31:55 UTC 2023 , Edited by admin on Fri Dec 15 21:31:55 UTC 2023
|
PRIMARY | |||
|
13ZPK7A4MJ
Created by
admin on Fri Dec 15 21:31:55 UTC 2023 , Edited by admin on Fri Dec 15 21:31:55 UTC 2023
|
PRIMARY | |||
|
9846588
Created by
admin on Fri Dec 15 21:31:55 UTC 2023 , Edited by admin on Fri Dec 15 21:31:55 UTC 2023
|
PRIMARY | |||
|
Remogliflozin
Created by
admin on Fri Dec 15 21:31:55 UTC 2023 , Edited by admin on Fri Dec 15 21:31:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|